Assistant professor Erasmus School of Health Policy & Management Health Technology Assessment (HTA)
- Location
- Burg. Oudlaan 50, Rotterdam
- thielen@eshpm.eur.nl
More information
‹ Back to overview
Profile
- VJ Nijenhuis, J Brouwer, R Delewi, RS Hermanides, W Holvoet, CLF Dubois, P Frambach, B De Bruyne, GK van Houwelingen, JAS Van Der Heyden, P Toušek, F van der Kley, I Buysschaert, CE Schotborgh, B Ferdinande, P van der Harst, J Roosen, J Peper, Frederick Thielen, L Veenstra, DRPP Chan Pin Yin, MJ Swaans, BJWM Rensing, A van 't Hof, L Timmers, JC Kelder, P Stella, J Baan & J ten Berg (2020) - Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation - New England Journal of Medicine, 382 (18), 1696-1707 - doi: 10.1056/NEJMoa1915152 - [link]
- Frederick Thielen, A van Dongen-Leunis, AMM Arons, JR Ladestein & PR Hoogerbrugge (2020) - Cost?effectiveness of Anti?CD19 chimeric antigen receptor T?Cell therapy in pediatric relapsed/refractory B?cell acute lymphoblastic leukemia. A societal view - European Journal of Haematology, 105 (2) - doi: 10.1111/ejh.13427 - [link]
- Frederick Thielen, Maite Houwing, Marjon Cnossen, IA Hadithy-Irgiztseva, Jan Hazelzet, Carin Groot, Anne Pagter & Hedwig Blommestein (2020) - Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country - Pediatric Blood & Cancer, 67 (9) - doi: 10.1002/pbc.28588
- BFM Wijnen, Frederick Thielen, S Konings, T Feenstra, M van der Gaag, W Veling, L De Haan, H Ising, M Hiligsmann, SMAA Evers, F Smit & J Lokkerbol (2019) - Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis - Expert review of pharmacoeconomics & outcomes research - doi: 10.1080/14737167.2019.1632194
- Frederick Thielen, NC Büyükkaramikli, R Riemsma, D Fayter, N Armstrong, C-Y Wei, V Huertas Carrera, K Misso, G Worthy, J Kleijnen & Isaac Corro Ramos (2018) - Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma - Pharmacoeconomics (Print) - doi: 10.1007/s40273-018-0740-4 - [link]
- Frederick Thielen, Hedwig Blommestein, LEM Oosten, FG Calkoen, AC Lankester, JJ Zwaginga, K Le Blanc, A Redondo, F Sánchez?Guijo, M Algeri, F (Franco) Locatelli, WE Fibbe & Carin Groot (2018) - Second?line treatment for acute graft?versus?host disease with mesenchymal stromal cells: A decision model. - European Journal of Haematology, 101 (5), 676-683 - doi: 10.1111/ejh.13158 - [link]
- LEM Oosten, MED Chamuleau, Frederick Thielen, LC de Wreede, Claire Siemes, Jeanette Doorduijn, OS Smeekes, MJ Kersten, L Hardi, JW Baars, AMP Demandt, WBC Stevens, GW Nijland, Carin Groot, PM Kluin, D de Jong & H Veelken (2017) - Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens - Annals of Hematology, 97 (2), 255-266 - doi: 10.1007/s00277-017-3167-7 - [link]
- Frederick Thielen, M Ten Have, R De Graaf, P Cuijpers, A Beekman & SMAA Evers (2016) - Long-term economic consequences of child maltreatment: a population-based study - European Child & Adolescent Psychiatry, 1-9 - doi: 10.1007/s00787-016-0850-5
- Frederick Thielen, Hedwig Blommestein & Carin Groot (2016) - Using appropriate methods in cost-effectiveness analyses: the case of allogeneic hematopoietic cell transplantation in sickle cell disease - Biology of Blood and Marrow Transplantation, 22 (11), 2109-2110 - doi: 10.1016/j.bbmt.2016.08.022
- Frederick Thielen, GAPG van Mastrigt, LT (Laura) Burgers, WM (Wichor) Bramer, HJM Majoie, SMAA Evers & J Kleijnen (2016) - How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3) - Expert review of pharmacoeconomics & outcomes research, 16 (6), 1-17 - doi: 10.1080/14737167.2016.1246962
- K Ruggeri, JP Stuhlreyer, J Immonen, S Mareva, AF Paul, A Robbiani, Frederick Thielen, A Gelashvili, F Cavassini & F Naru (2018) - Policy evaluation - Routledge
- Frederick Thielen (2016) - Entering your heart: how barely tested medical innovations find their way into clinical practice - Creative Commons License CC BY-NC
- Frederick Thielen (2020) - Current Challenges in Health Technology Assessment: Assessing costs and cost-effectiveness of novel treatments in haemato-oncology - EUR
- VJ Nijenhuis, J Brouwer, R Delewi, RS Hermanides, W Holvoet, CLF Dubois, P Frambach, B De Bruyne, GK van Houwelingen, JAS Van Der Heyden, P Toušek, F van der Kley, I Buysschaert, CE Schotborgh, B Ferdinande, P van der Harst, J Roosen, J Peper, Frederick Thielen, L Veenstra, DRPP Chan Pin Yin, MJ Swaans, BJWM Rensing, A van 't Hof, L Timmers, JC Kelder, P Stella, J Baan & J ten Berg (2020) - Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation - New England Journal of Medicine, 382 (18), 1696-1707 - doi: 10.1056/NEJMoa1915152 - [link]
- Frederick Thielen, A van Dongen-Leunis, AMM Arons, JR Ladestein & PR Hoogerbrugge (2020) - Cost?effectiveness of Anti?CD19 chimeric antigen receptor T?Cell therapy in pediatric relapsed/refractory B?cell acute lymphoblastic leukemia. A societal view - European Journal of Haematology, 105 (2) - doi: 10.1111/ejh.13427 - [link]
- Frederick Thielen, Maite Houwing, Marjon Cnossen, IA Hadithy-Irgiztseva, Jan Hazelzet, Carin Groot, Anne Pagter & Hedwig Blommestein (2020) - Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country - Pediatric Blood & Cancer, 67 (9) - doi: 10.1002/pbc.28588
- BFM Wijnen, Frederick Thielen, S Konings, T Feenstra, M van der Gaag, W Veling, L De Haan, H Ising, M Hiligsmann, SMAA Evers, F Smit & J Lokkerbol (2019) - Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis - Expert review of pharmacoeconomics & outcomes research - doi: 10.1080/14737167.2019.1632194
- Frederick Thielen, NC Büyükkaramikli, R Riemsma, D Fayter, N Armstrong, C-Y Wei, V Huertas Carrera, K Misso, G Worthy, J Kleijnen & Isaac Corro Ramos (2018) - Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma - Pharmacoeconomics (Print) - doi: 10.1007/s40273-018-0740-4 - [link]
- Frederick Thielen, Hedwig Blommestein, LEM Oosten, FG Calkoen, AC Lankester, JJ Zwaginga, K Le Blanc, A Redondo, F Sánchez?Guijo, M Algeri, F (Franco) Locatelli, WE Fibbe & Carin Groot (2018) - Second?line treatment for acute graft?versus?host disease with mesenchymal stromal cells: A decision model. - European Journal of Haematology, 101 (5), 676-683 - doi: 10.1111/ejh.13158 - [link]
- LEM Oosten, MED Chamuleau, Frederick Thielen, LC de Wreede, Claire Siemes, Jeanette Doorduijn, OS Smeekes, MJ Kersten, L Hardi, JW Baars, AMP Demandt, WBC Stevens, GW Nijland, Carin Groot, PM Kluin, D de Jong & H Veelken (2017) - Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens - Annals of Hematology, 97 (2), 255-266 - doi: 10.1007/s00277-017-3167-7 - [link]
- Frederick Thielen, M Ten Have, R De Graaf, P Cuijpers, A Beekman & SMAA Evers (2016) - Long-term economic consequences of child maltreatment: a population-based study - European Child & Adolescent Psychiatry, 1-9 - doi: 10.1007/s00787-016-0850-5
- Frederick Thielen, Hedwig Blommestein & Carin Groot (2016) - Using appropriate methods in cost-effectiveness analyses: the case of allogeneic hematopoietic cell transplantation in sickle cell disease - Biology of Blood and Marrow Transplantation, 22 (11), 2109-2110 - doi: 10.1016/j.bbmt.2016.08.022
- Frederick Thielen, GAPG van Mastrigt, LT (Laura) Burgers, WM (Wichor) Bramer, HJM Majoie, SMAA Evers & J Kleijnen (2016) - How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3) - Expert review of pharmacoeconomics & outcomes research, 16 (6), 1-17 - doi: 10.1080/14737167.2016.1246962
- VJ Nijenhuis, J Brouwer, R Delewi, RS Hermanides, W Holvoet, CLF Dubois, P Frambach, B De Bruyne, GK van Houwelingen, JAS Van Der Heyden, P Toušek, F van der Kley, I Buysschaert, CE Schotborgh, B Ferdinande, P van der Harst, J Roosen, J Peper, Frederick Thielen, L Veenstra, DRPP Chan Pin Yin, MJ Swaans, BJWM Rensing, A van 't Hof, L Timmers, JC Kelder, P Stella, J Baan & J ten Berg (2020) - Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation - New England Journal of Medicine, 382 (18), 1696-1707 - doi: 10.1056/NEJMoa1915152 - [link]
- Frederick Thielen, A van Dongen-Leunis, AMM Arons, JR Ladestein & PR Hoogerbrugge (2020) - Cost?effectiveness of Anti?CD19 chimeric antigen receptor T?Cell therapy in pediatric relapsed/refractory B?cell acute lymphoblastic leukemia. A societal view - European Journal of Haematology, 105 (2) - doi: 10.1111/ejh.13427 - [link]
- Frederick Thielen, Maite Houwing, Marjon Cnossen, IA Hadithy-Irgiztseva, Jan Hazelzet, Carin Groot, Anne Pagter & Hedwig Blommestein (2020) - Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country - Pediatric Blood & Cancer, 67 (9) - doi: 10.1002/pbc.28588
- BFM Wijnen, Frederick Thielen, S Konings, T Feenstra, M van der Gaag, W Veling, L De Haan, H Ising, M Hiligsmann, SMAA Evers, F Smit & J Lokkerbol (2019) - Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis - Expert review of pharmacoeconomics & outcomes research - doi: 10.1080/14737167.2019.1632194
- Frederick Thielen, NC Büyükkaramikli, R Riemsma, D Fayter, N Armstrong, C-Y Wei, V Huertas Carrera, K Misso, G Worthy, J Kleijnen & Isaac Corro Ramos (2018) - Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma - Pharmacoeconomics (Print) - doi: 10.1007/s40273-018-0740-4 - [link]
- Frederick Thielen, Hedwig Blommestein, LEM Oosten, FG Calkoen, AC Lankester, JJ Zwaginga, K Le Blanc, A Redondo, F Sánchez?Guijo, M Algeri, F (Franco) Locatelli, WE Fibbe & Carin Groot (2018) - Second?line treatment for acute graft?versus?host disease with mesenchymal stromal cells: A decision model. - European Journal of Haematology, 101 (5), 676-683 - doi: 10.1111/ejh.13158 - [link]
- LEM Oosten, MED Chamuleau, Frederick Thielen, LC de Wreede, Claire Siemes, Jeanette Doorduijn, OS Smeekes, MJ Kersten, L Hardi, JW Baars, AMP Demandt, WBC Stevens, GW Nijland, Carin Groot, PM Kluin, D de Jong & H Veelken (2017) - Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens - Annals of Hematology, 97 (2), 255-266 - doi: 10.1007/s00277-017-3167-7 - [link]
- Frederick Thielen, M Ten Have, R De Graaf, P Cuijpers, A Beekman & SMAA Evers (2016) - Long-term economic consequences of child maltreatment: a population-based study - European Child & Adolescent Psychiatry, 1-9 - doi: 10.1007/s00787-016-0850-5
- Frederick Thielen, Hedwig Blommestein & Carin Groot (2016) - Using appropriate methods in cost-effectiveness analyses: the case of allogeneic hematopoietic cell transplantation in sickle cell disease - Biology of Blood and Marrow Transplantation, 22 (11), 2109-2110 - doi: 10.1016/j.bbmt.2016.08.022
- Frederick Thielen, GAPG van Mastrigt, LT (Laura) Burgers, WM (Wichor) Bramer, HJM Majoie, SMAA Evers & J Kleijnen (2016) - How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3) - Expert review of pharmacoeconomics & outcomes research, 16 (6), 1-17 - doi: 10.1080/14737167.2016.1246962
- K Ruggeri, JP Stuhlreyer, J Immonen, S Mareva, AF Paul, A Robbiani, Frederick Thielen, A Gelashvili, F Cavassini & F Naru (2018) - Policy evaluation - Routledge
- Frederick Thielen (2016) - Entering your heart: how barely tested medical innovations find their way into clinical practice - Creative Commons License CC BY-NC
- K Ruggeri, JP Stuhlreyer, J Immonen, S Mareva, AF Paul, A Robbiani, Frederick Thielen, A Gelashvili, F Cavassini & F Naru (2018) - Policy evaluation - Routledge
- Frederick Thielen (2016) - Entering your heart: how barely tested medical innovations find their way into clinical practice - Creative Commons License CC BY-NC
- Frederick Thielen (2020) - Current Challenges in Health Technology Assessment: Assessing costs and cost-effectiveness of novel treatments in haemato-oncology - EUR
- Frederick Thielen (2020) - Current Challenges in Health Technology Assessment: Assessing costs and cost-effectiveness of novel treatments in haemato-oncology - EUR
- Frederick Thielen (2018) - Best Student Poster Presentation
- Frederick Thielen (2018) - Best Student Poster Presentation
TriData
- Begindatum goedkeuring
- februari 2021
- Einddatum goedkeuring
- januari 2024
- Plaats
- UTRECHT
- Beschrijving
- Teacher Statistical Programming & Data Science
TriData
- Begindatum goedkeuring
- februari 2021
- Einddatum goedkeuring
- januari 2024
- Plaats
- UTRECHT
- Beschrijving
- Teacher Statistical Programming & Data Science
Master Thesis HE
- Year
- 2021
- Year Level
- master, master
- Course Code
- GW4592M
Master Thesis HEPL
- Level
- master
- Year
- 2021
- Year Level
- master
- Course Code
- GW4555M
Health Technology Assessment
- Year
- 2021
- Year Level
- master, master, master
- Course Code
- GW4546M
Pharmaceutical Pricing and Market Access
- Year
- 2021
- Year Level
- master, master, master, master
- Course Code
- GW4575M
Master HEPL-HE 2021-2022
- Year
- 2021
- Course Code
- GWMTTHEPL
Health Technology Assessment (Eu-HEM)
- Level
- master
- Year
- 2021
- Year Level
- master
- Course Code
- GW4585M
Master Thesis HE
- Year
- 2021
- Year Level
- master, master
- Course Code
- GW4592M
Master Thesis HEPL
- Level
- master
- Year
- 2021
- Year Level
- master
- Course Code
- GW4555M
Health Technology Assessment
- Year
- 2021
- Year Level
- master, master, master
- Course Code
- GW4546M
Pharmaceutical Pricing and Market Access
- Year
- 2021
- Year Level
- master, master, master, master
- Course Code
- GW4575M
Master HEPL-HE 2021-2022
- Year
- 2021
- Course Code
- GWMTTHEPL
Health Technology Assessment (Eu-HEM)
- Level
- master
- Year
- 2021
- Year Level
- master
- Course Code
- GW4585M